Registry for patients with early digestive tract neoplasms treated by endoscopic submucosal dissection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on patients with pre-neoplastic or early neoplastic lesions in the digestive tract who are treated using the endoscopic submucosal dissection (ESD) technique. Each case will be documented in an electronic record, ensuring patient consent and compliance with legal requirements. The goal is to gather comprehensive information to improve understanding and treatment outcomes for these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa
* non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa
* age \> 18 years old
* informed consent

Exclusion Criteria:

* age \< 18 years old
* no informed consent

Where it's running

• "Agrippa Ionescu" Hospital
  Bucharest, Romania Recruiting

Study contacts

• Principal investigator: Mihai L Ciocirlan, Associate Professor — Carol Davila University of Medicine and Pharmacy
• Study coordinator: Ciocirlan L Mihai, Associate Professor
• Email: mihai.ciocirlan@umfcd.ro
• Phone: 0040722322625

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining brain changes in colorectal cancer patients undergoing chemotherapy

  This study is trying to see how chemotherapy affects thinking and memory in people with colorectal cancer.

  Recruiting Parkview Health · Fort Wayne, Indiana · NCT05014399

• Perioperative biomarker monitoring to spot complications after colorectal and gastric cancer surgery

  This randomized trial tests whether checking inflammatory and metabolic biomarkers during the perioperative period helps detect postoperative problems early in adults having colorectal or gastric cancer surgery.

  Recruiting Bucharest Emergency Hospital · Bucharest, Bucharest · NCT07881133

• Lenvatinib with nivolumab and chemotherapy for metastatic gastric cancer with malignant ascites

  This trial tests whether adding lenvatinib to nivolumab plus chemotherapy helps people with metastatic gastric or gastroesophageal junction adenocarcinoma who have peritoneal metastases and significant malignant ascites.

  Recruiting Phase 1/2 Asan Medical Center · Seoul · NCT07149090

• 18F-FAPI PET/CT and laparoscopy for staging advanced stomach cancer

  This trial tests whether an 18F-FAPI PET/CT scan, used with laparoscopy, can better find spread of advanced stomach cancer and help doctors avoid unnecessary surgery.

  Recruiting Phase 2/3 Leiden University Medical Center · Almelo and 9 other locations · NCT07018661

• Evaluating outcomes in gastric cancer patients before and after a Tumor Board implementation

  This study is trying to see if having a team of experts work together improves the surgery and treatment results for people with gastric cancer.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, IT · NCT06923449

• Neoadjuvant zolbetuximab with docetaxel, oxaliplatin and S-1 for locally advanced stomach cancer

  This study will test whether adding zolbetuximab to docetaxel, oxaliplatin, and S-1 before surgery helps people with locally advanced, CLDN18.2-positive stomach cancer shrink tumors and have better outcomes.

  Recruiting at 2 sites Phase 1/2 Asan Medical Center · Seoul and 1 other locations · NCT06732856

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.